Press "Enter" to skip to content

The psychedelic renaissance | Stephen Bright | TEDxUniMelb


so 1943 albert hofmann

so 1943 albert hofmann a swiss chemist was developing potential

a swiss chemist was developing potential

a swiss chemist was developing potential medications for the treatment of

medications for the treatment of

medications for the treatment of migraine when he’s accidentally exposed

migraine when he’s accidentally exposed

migraine when he’s accidentally exposed to one he found a little odd and went

to one he found a little odd and went

to one he found a little odd and went home but he had a pretty good idea of

home but he had a pretty good idea of

home but he had a pretty good idea of what he’d been exposed to so three days

what he’d been exposed to so three days

what he’d been exposed to so three days later he went back to the lab and took

later he went back to the lab and took

later he went back to the lab and took 250 micrograms of LSD in those days that

250 micrograms of LSD in those days that

250 micrograms of LSD in those days that was seen as a minut amount to be taking

was seen as a minut amount to be taking

was seen as a minut amount to be taking drugs and medications were administered

drugs and medications were administered

drugs and medications were administered in the milligram range not the microgram

in the milligram range not the microgram

in the milligram range not the microgram range but we know now that was a pretty

range but we know now that was a pretty

range but we know now that was a pretty solid dose so as the effects came on he

solid dose so as the effects came on he

solid dose so as the effects came on he realized the lab was not the right place

realized the lab was not the right place

realized the lab was not the right place to be and so hot Tony’s bicycle and he

to be and so hot Tony’s bicycle and he

to be and so hot Tony’s bicycle and he started riding home and he describes the

started riding home and he describes the

started riding home and he describes the vivid imagery the beauty in nature and

vivid imagery the beauty in nature and

vivid imagery the beauty in nature and he went on to self experiment with LSD

he went on to self experiment with LSD

he went on to self experiment with LSD noting that it had these profound

noting that it had these profound

noting that it had these profound effects but he didn’t know what the

effects but he didn’t know what the

effects but he didn’t know what the clinical utility of it was so Ellis then

clinical utility of it was so Ellis then

clinical utility of it was so Ellis then was sent out to researchers around the

was sent out to researchers around the

was sent out to researchers around the world and it led to thousands of papers

world and it led to thousands of papers

world and it led to thousands of papers being published demonstrating that LSD

being published demonstrating that LSD

being published demonstrating that LSD assisted psychotherapy was effective in

assisted psychotherapy was effective in

assisted psychotherapy was effective in treating a range of psychological

treating a range of psychological

treating a range of psychological disorders one of those researchers was

disorders one of those researchers was

disorders one of those researchers was Timothy Leary professor in psychology at

Timothy Leary professor in psychology at

Timothy Leary professor in psychology at Harvard University

Harvard University

Harvard University but unfortunately Timothy’s

but unfortunately Timothy’s

but unfortunately Timothy’s methodologies got a little loose at the

methodologies got a little loose at the

methodologies got a little loose at the end of the end there he was giving out

end of the end there he was giving out

end of the end there he was giving out LSD to anyone that would pretty much

LSD to anyone that would pretty much

LSD to anyone that would pretty much take it and so he was fired from Harvard

take it and so he was fired from Harvard

take it and so he was fired from Harvard but there this this was a time of

but there this this was a time of

but there this this was a time of Cultural Revolution young Americans were

Cultural Revolution young Americans were

Cultural Revolution young Americans were taking LSD and mass and Leary became

taking LSD and mass and Leary became

taking LSD and mass and Leary became their figurehead he was seen on national

their figurehead he was seen on national

their figurehead he was seen on national television telling the youth to turn on

television telling the youth to turn on

television telling the youth to turn on tune in drop out this was not a good

tune in drop out this was not a good

tune in drop out this was not a good time for a cultural revolution the US

time for a cultural revolution the US

time for a cultural revolution the US was at war with Vietnam and the

was at war with Vietnam and the

was at war with Vietnam and the authorities noticed that

authorities noticed that

authorities noticed that that was protesting the war we’re taking

that was protesting the war we’re taking

that was protesting the war we’re taking LSD

LSD

LSD so LSD was seen as a threat to the very

so LSD was seen as a threat to the very

so LSD was seen as a threat to the very American institution and in 1968 it was

American institution and in 1968 it was

American institution and in 1968 it was banned and this is the start of the war

banned and this is the start of the war

banned and this is the start of the war on drugs it was them bandhans nationally

on drugs it was them bandhans nationally

on drugs it was them bandhans nationally in 1971 the same year President Nixon

in 1971 the same year President Nixon

in 1971 the same year President Nixon said that drugs a public enemy number

said that drugs a public enemy number

said that drugs a public enemy number one the drugs he was referring to

one the drugs he was referring to

one the drugs he was referring to psychedelics sadly it also meant the end

psychedelics sadly it also meant the end

psychedelics sadly it also meant the end of psychedelic science with prohibition

of psychedelic science with prohibition

of psychedelic science with prohibition came a propaganda campaign we’ve met so

came a propaganda campaign we’ve met so

came a propaganda campaign we’ve met so powerful they’re being perpetuated into

powerful they’re being perpetuated into

powerful they’re being perpetuated into present day one myth is that LSD may be

present day one myth is that LSD may be

present day one myth is that LSD may be contaminated with the poison strychnine

contaminated with the poison strychnine

contaminated with the poison strychnine so powerful is this myth but it’s

so powerful is this myth but it’s

so powerful is this myth but it’s contained in the fourth edition of the

contained in the fourth edition of the

contained in the fourth edition of the Diagnostic and Statistical Manual of

Diagnostic and Statistical Manual of

Diagnostic and Statistical Manual of Mental Disorders published by the

Mental Disorders published by the

Mental Disorders published by the American Psychiatric Association where

American Psychiatric Association where

American Psychiatric Association where it states that one of the dangers of

it states that one of the dangers of

it states that one of the dangers of taking LSD is exposure to strychnine now

taking LSD is exposure to strychnine now

taking LSD is exposure to strychnine now this is the diagnostic manual that

this is the diagnostic manual that

this is the diagnostic manual that psychologists and psychiatrists around

psychologists and psychiatrists around

psychologists and psychiatrists around the world use fortunately in its most

the world use fortunately in its most

the world use fortunately in its most recent edition published in 2013

recent edition published in 2013

recent edition published in 2013 reference that this has been removed

reference that this has been removed

reference that this has been removed because there’s never been any

because there’s never been any

because there’s never been any strychnine detected there’s no evidence

strychnine detected there’s no evidence

strychnine detected there’s no evidence the indicators strychnine would be

the indicators strychnine would be

the indicators strychnine would be contained in LSD and yet still it was

contained in LSD and yet still it was

contained in LSD and yet still it was published in this very distinguished

published in this very distinguished

published in this very distinguished book there’s the concern that if you

book there’s the concern that if you

book there’s the concern that if you take LSD gonna lose your mind in a

take LSD gonna lose your mind in a

take LSD gonna lose your mind in a literature review of all the clinical

literature review of all the clinical

literature review of all the clinical studies that were conducted before the

studies that were conducted before the

studies that were conducted before the prohibition of LSD they found that less

prohibition of LSD they found that less

prohibition of LSD they found that less than point zero one percent of people

than point zero one percent of people

than point zero one percent of people that participated in the trials

that participated in the trials

that participated in the trials experienced any symptoms of psychosis

experienced any symptoms of psychosis

experienced any symptoms of psychosis either during or after their psychedelic

either during or after their psychedelic

either during or after their psychedelic assisted psychotherapy and it’s

assisted psychotherapy and it’s

assisted psychotherapy and it’s important here that I distinguish

important here that I distinguish

important here that I distinguish between the medical application of

between the medical application of

between the medical application of psychedelic drugs which I’m talking

psychedelic drugs which I’m talking

psychedelic drugs which I’m talking about and the recreational use of those

about and the recreational use of those

about and the recreational use of those drugs which we’ve become so familiar

drugs which we’ve become so familiar

drugs which we’ve become so familiar with then in 1990 dr. Rick Strassman a

with then in 1990 dr. Rick Strassman a

with then in 1990 dr. Rick Strassman a psychiatrist who was trained during the

psychiatrist who was trained during the

psychiatrist who was trained during the era of psychedelic therapy and

era of psychedelic therapy and

era of psychedelic therapy and dreamed of being a psychedelic therapist

dreamed of being a psychedelic therapist

dreamed of being a psychedelic therapist was able to re-engage in psychedelic

was able to re-engage in psychedelic

was able to re-engage in psychedelic research he was encouraged by his

research he was encouraged by his

research he was encouraged by his supervisor to examine the drug

supervisor to examine the drug

supervisor to examine the drug dimethyltryptamine because university

dimethyltryptamine because university

dimethyltryptamine because university would know it was

dimethyltryptamine his possible potent

dimethyltryptamine his possible potent psychedelic night in to humankind

psychedelic night in to humankind

psychedelic night in to humankind it’s used by shaman in South America to

it’s used by shaman in South America to

it’s used by shaman in South America to enter the spirit world

enter the spirit world

enter the spirit world it was encouraged to do some small-scale

it was encouraged to do some small-scale

it was encouraged to do some small-scale blood studies just looking at the

blood studies just looking at the

blood studies just looking at the metabolism of the drug but what he found

metabolism of the drug but what he found

metabolism of the drug but what he found far more profound were the participants

far more profound were the participants

far more profound were the participants experiences they reported being

experiences they reported being

experiences they reported being transported to parallel dimensions where

transported to parallel dimensions where

transported to parallel dimensions where there were entities communicating with

there were entities communicating with

there were entities communicating with them eventually Strassmann wrapped up

them eventually Strassmann wrapped up

them eventually Strassmann wrapped up his research because he felt it was

his research because he felt it was

his research because he felt it was unethical to be pushing people off this

unethical to be pushing people off this

unethical to be pushing people off this psychological abyss without knowing

psychological abyss without knowing

psychological abyss without knowing where they were going but it was too

where they were going but it was too

where they were going but it was too late

late

late he’d opened Pandora’s box and we

he’d opened Pandora’s box and we

he’d opened Pandora’s box and we subsequently have seen an explosion of

subsequently have seen an explosion of

subsequently have seen an explosion of psychedelic research what’s now being

psychedelic research what’s now being

psychedelic research what’s now being referred to as the psychedelic

referred to as the psychedelic

referred to as the psychedelic Renaissance so what have we learned

Renaissance so what have we learned

Renaissance so what have we learned we’ve learnt a lot about the brain but

we’ve learnt a lot about the brain but

we’ve learnt a lot about the brain but what really excites me is a clinically

what really excites me is a clinically

what really excites me is a clinically trained psychologist is mounting

trained psychologist is mounting

trained psychologist is mounting evidence that psychedelic assisted

evidence that psychedelic assisted

evidence that psychedelic assisted psychotherapy are effective in the

psychotherapy are effective in the

psychotherapy are effective in the treatment for people who don’t respond

treatment for people who don’t respond

treatment for people who don’t respond to current therapies for a range of

to current therapies for a range of

to current therapies for a range of mental health conditions so let’s look

mental health conditions so let’s look

mental health conditions so let’s look at the evidence we used to think that

at the evidence we used to think that

at the evidence we used to think that psychedelics turned on parts of the mind

psychedelics turned on parts of the mind

psychedelics turned on parts of the mind we’ve now learned what it actually does

we’ve now learned what it actually does

we’ve now learned what it actually does is turn off a part of the brain called

is turn off a part of the brain called

is turn off a part of the brain called the default mode network the default

the default mode network the default

the default mode network the default mode Network is a series of neural

mode Network is a series of neural

mode Network is a series of neural pathways that connect certain areas of

pathways that connect certain areas of

pathways that connect certain areas of the brain together while preventing

the brain together while preventing

the brain together while preventing other parts of the brain crosstalking

other parts of the brain crosstalking

other parts of the brain crosstalking it’s active whenever you’re in a wakeful

it’s active whenever you’re in a wakeful

it’s active whenever you’re in a wakeful state it becomes more active when you

state it becomes more active when you

state it becomes more active when you engage in autobiographical narration you

engage in autobiographical narration you

engage in autobiographical narration you know that little voice in your head and

know that little voice in your head and

know that little voice in your head and it becomes hyperactive when people

it becomes hyperactive when people

it becomes hyperactive when people experience depression and OCD so what

experience depression and OCD so what

experience depression and OCD so what happens with psychedelics

happens with psychedelics

happens with psychedelics is it actually turns the default mode

is it actually turns the default mode

is it actually turns the default mode Network off so what does that look like

Network off so what does that look like

Network off so what does that look like the picture you can see here is the

the picture you can see here is the

the picture you can see here is the brain not on psychedelics and the brain

brain not on psychedelics and the brain

brain not on psychedelics and the brain on psychedelics see all the inter

on psychedelics see all the inter

on psychedelics see all the inter communication and connectivity that’s

communication and connectivity that’s

communication and connectivity that’s happening between parts of the brain

happening between parts of the brain

happening between parts of the brain that would never normally communicate

that would never normally communicate

that would never normally communicate and it’s been hypothesized that this is

and it’s been hypothesized that this is

and it’s been hypothesized that this is the reason that people experience

the reason that people experience

the reason that people experience creativity and spiritual have spiritual

creativity and spiritual have spiritual

creativity and spiritual have spiritual experiences when they take psychedelic

experiences when they take psychedelic

experiences when they take psychedelic drugs but more importantly it’s been

drugs but more importantly it’s been

drugs but more importantly it’s been hypothesized that this increased

hypothesized that this increased

hypothesized that this increased communication and increased connectivity

communication and increased connectivity

communication and increased connectivity in the brain could help treat people who

in the brain could help treat people who

in the brain could help treat people who are treatment resistant with depression

are treatment resistant with depression

are treatment resistant with depression because with all this interconnectivity

because with all this interconnectivity

because with all this interconnectivity happening in the brain perhaps they can

happening in the brain perhaps they can

happening in the brain perhaps they can overcome their entrenched beliefs and

overcome their entrenched beliefs and

overcome their entrenched beliefs and see the world from a completely

see the world from a completely

see the world from a completely different perspective and this has been

different perspective and this has been

different perspective and this has been tested recently by a research group at

tested recently by a research group at

tested recently by a research group at Imperial College London they gave people

Imperial College London they gave people

Imperial College London they gave people psilocybin which is the active

psilocybin which is the active

psilocybin which is the active ingredient in magic mushrooms to 12

ingredient in magic mushrooms to 12

ingredient in magic mushrooms to 12 people who are treatment resistant in

people who are treatment resistant in

people who are treatment resistant in the context of psychotherapy the results

the context of psychotherapy the results

the context of psychotherapy the results when given the psilocybin there was a

when given the psilocybin there was a

when given the psilocybin there was a significant reduction in depression

significant reduction in depression

significant reduction in depression symptoms and this was maintained for

symptoms and this was maintained for

symptoms and this was maintained for many people at the three-month follow-up

many people at the three-month follow-up

many people at the three-month follow-up what’s more interesting is because they

what’s more interesting is because they

what’s more interesting is because they were doing brain scans at the time the

were doing brain scans at the time the

were doing brain scans at the time the people that had those survived

people that had those survived

people that had those survived significant reductions in in depressive

significant reductions in in depressive

significant reductions in in depressive symptoms were those whose default mode

symptoms were those whose default mode

symptoms were those whose default mode network was turned off the most

network was turned off the most

network was turned off the most addiction is another area where we see

addiction is another area where we see

addiction is another area where we see poor outcomes a group at johns hopkins

poor outcomes a group at johns hopkins

poor outcomes a group at johns hopkins university conducted a trial of

university conducted a trial of

university conducted a trial of psilocybin assisted psychotherapy for

psilocybin assisted psychotherapy for

psilocybin assisted psychotherapy for the treatment of tobacco addiction the

the treatment of tobacco addiction the

the treatment of tobacco addiction the results were astonishing

results were astonishing

results were astonishing they found that 80% had quit smoking at

they found that 80% had quit smoking at

they found that 80% had quit smoking at a six-month follow-up when you consider

a six-month follow-up when you consider

a six-month follow-up when you consider the leading pharmaceutical today for the

the leading pharmaceutical today for the

the leading pharmaceutical today for the treatment of tobacco cessation it’s only

treatment of tobacco cessation it’s only

treatment of tobacco cessation it’s only effective for 25% of people this group

effective for 25% of people this group

effective for 25% of people this group is now recruiting more petition

is now recruiting more petition

is now recruiting more petition fencing conducting clinical trials

fencing conducting clinical trials

fencing conducting clinical trials together further evidence for this

together further evidence for this

together further evidence for this treatment meanwhile at New York

treatment meanwhile at New York

treatment meanwhile at New York University they’re recruiting a hundred

University they’re recruiting a hundred

University they’re recruiting a hundred and forty people to conduct a clinical

and forty people to conduct a clinical

and forty people to conduct a clinical trial to evaluate whether psychedelic

trial to evaluate whether psychedelic

trial to evaluate whether psychedelic assisted psychotherapy is effective for

assisted psychotherapy is effective for

assisted psychotherapy is effective for people with alcohol dependence we’ve

people with alcohol dependence we’ve

people with alcohol dependence we’ve also found that psychedelics can help

also found that psychedelics can help

also found that psychedelics can help people die with dignity numerous studies

people die with dignity numerous studies

people die with dignity numerous studies have been published now clinical trials

have been published now clinical trials

have been published now clinical trials showing that when psychedelic assisted

showing that when psychedelic assisted

showing that when psychedelic assisted therapy is provided to people who are

therapy is provided to people who are

therapy is provided to people who are experiencing end of stage cancer they

experiencing end of stage cancer they

experiencing end of stage cancer they see a significant reduction in anxiety

see a significant reduction in anxiety

see a significant reduction in anxiety symptoms an increase in the quality

symptoms an increase in the quality

symptoms an increase in the quality improving quality of their life and

improving quality of their life and

improving quality of their life and their relationships with their

their relationships with their

their relationships with their significant others improve another

significant others improve another

significant others improve another disorder that’s extremely disability

disorder that’s extremely disability

disorder that’s extremely disability ting is post-traumatic stress disorder

ting is post-traumatic stress disorder

ting is post-traumatic stress disorder the current treatments we have are only

the current treatments we have are only

the current treatments we have are only effective for 30% of people those that

effective for 30% of people those that

effective for 30% of people those that don’t respond to treatment are at risk

don’t respond to treatment are at risk

don’t respond to treatment are at risk of addiction of relationship breakdown

of addiction of relationship breakdown

of addiction of relationship breakdown and suicide in the first clinical trial

and suicide in the first clinical trial

and suicide in the first clinical trial of mdma-assisted psychotherapy for

of mdma-assisted psychotherapy for

of mdma-assisted psychotherapy for people who are treat resistant with

people who are treat resistant with

people who are treat resistant with post-traumatic stress disorder found

post-traumatic stress disorder found

post-traumatic stress disorder found that there was a significant improvement

that there was a significant improvement

that there was a significant improvement in fact 83% of participants no longer

in fact 83% of participants no longer

in fact 83% of participants no longer met the diagnostic criteria for PTSD

met the diagnostic criteria for PTSD

met the diagnostic criteria for PTSD after receiving mdma-assisted

after receiving mdma-assisted

after receiving mdma-assisted psychotherapy and this was sustained for

psychotherapy and this was sustained for

psychotherapy and this was sustained for three and a half years follow-up this

three and a half years follow-up this

three and a half years follow-up this study has now been replicated in Israel

study has now been replicated in Israel

study has now been replicated in Israel Colorado Canada Switzerland and the

Colorado Canada Switzerland and the

Colorado Canada Switzerland and the sponsor of the trial the

sponsor of the trial the

sponsor of the trial the multidisciplinary Association for

multidisciplinary Association for

multidisciplinary Association for psychedelic studies has been able to

psychedelic studies has been able to

psychedelic studies has been able to pull that data they have approached the

pull that data they have approached the

pull that data they have approached the US Food and Drug Administration and now

US Food and Drug Administration and now

US Food and Drug Administration and now have approval to conduct phase 3

have approval to conduct phase 3

have approval to conduct phase 3 clinical trials why is this significant

clinical trials why is this significant

clinical trials why is this significant phase 3 clinical trials are the final

phase 3 clinical trials are the final

phase 3 clinical trials are the final stage before a drug becomes a medicine

stage before a drug becomes a medicine

stage before a drug becomes a medicine and so in the next few years

and so in the next few years

and so in the next few years we will see MDMA as a medicine for the

we will see MDMA as a medicine for the

we will see MDMA as a medicine for the treatment of PTSD in the u.s. so I

treatment of PTSD in the u.s. so I

treatment of PTSD in the u.s. so I mentioned the number of countries Israel

mentioned the number of countries Israel

mentioned the number of countries Israel Canada UK there’s other countries

Canada UK there’s other countries

Canada UK there’s other countries engaged in psychedelic Renaissance as

engaged in psychedelic Renaissance as

engaged in psychedelic Renaissance as well Brazil the Czech Republic even New

well Brazil the Czech Republic even New

well Brazil the Czech Republic even New Zealand but there’s one country I’ve not

Zealand but there’s one country I’ve not

Zealand but there’s one country I’ve not mentioned what is it why is there no

mentioned what is it why is there no

mentioned what is it why is there no psychedelic research in Australia well I

psychedelic research in Australia well I

psychedelic research in Australia well I can tell you it’s not through a lack of

can tell you it’s not through a lack of

can tell you it’s not through a lack of effort in 2011 given that I believe that

effort in 2011 given that I believe that

effort in 2011 given that I believe that these compounds these psychedelic drugs

these compounds these psychedelic drugs

these compounds these psychedelic drugs could assist in the suffering of

could assist in the suffering of

could assist in the suffering of hundreds of thousands of Australians I

hundreds of thousands of Australians I

hundreds of thousands of Australians I helped form psychedelic research in

helped form psychedelic research in

helped form psychedelic research in science and medicine Australia’s first

science and medicine Australia’s first

science and medicine Australia’s first and only not-for-profit incorporated

and only not-for-profit incorporated

and only not-for-profit incorporated organisation that has a mission to

organisation that has a mission to

organisation that has a mission to initiate fund and facilitate psychedelic

initiate fund and facilitate psychedelic

initiate fund and facilitate psychedelic research in Australia we’ve developed a

research in Australia we’ve developed a

research in Australia we’ve developed a strong collaboration with maps and so

strong collaboration with maps and so

strong collaboration with maps and so our first attempt was to conduct

our first attempt was to conduct

our first attempt was to conduct basically the same troll that they’ve

basically the same troll that they’ve

basically the same troll that they’ve been doing in the u.s. in Israel in

been doing in the u.s. in Israel in

been doing in the u.s. in Israel in Colorado in Switzerland

Colorado in Switzerland

Colorado in Switzerland except we wanted to focus on war

except we wanted to focus on war

except we wanted to focus on war veterans the reason being was strategic

veterans the reason being was strategic

veterans the reason being was strategic what kills more Australian soldiers than

what kills more Australian soldiers than

what kills more Australian soldiers than anything else

he’d been you beat me to the punch it’s

he’d been you beat me to the punch it’s not bombs it’s not so it’s it’s not

not bombs it’s not so it’s it’s not

not bombs it’s not so it’s it’s not bullets it’s suicide this is an epidemic

bullets it’s suicide this is an epidemic

bullets it’s suicide this is an epidemic we thought with this would gain public

we thought with this would gain public

we thought with this would gain public support and we submitted the research

support and we submitted the research

support and we submitted the research protocol to an independent research

protocol to an independent research

protocol to an independent research committee they had no problem with the

committee they had no problem with the

committee they had no problem with the methodology they didn’t have a problem

methodology they didn’t have a problem

methodology they didn’t have a problem with administering MDMA to war veterans

with administering MDMA to war veterans

with administering MDMA to war veterans with post-traumatic stress disorder that

with post-traumatic stress disorder that

with post-traumatic stress disorder that had not responded to treatment but they

had not responded to treatment but they

had not responded to treatment but they were concerned that it wasn’t being

were concerned that it wasn’t being

were concerned that it wasn’t being conducted in an academic environment so

conducted in an academic environment so

conducted in an academic environment so we sought out a professor who would come

we sought out a professor who would come

we sought out a professor who would come on board as the chief investigator he

on board as the chief investigator he

on board as the chief investigator he was based at a Victorian University and

was based at a Victorian University and

was based at a Victorian University and last year we submitted the protocol to

last year we submitted the protocol to

last year we submitted the protocol to that Victorian University’s Ethics

that Victorian University’s Ethics

that Victorian University’s Ethics Committee before it reached the ethics

Committee before it reached the ethics

Committee before it reached the ethics committee

committee

committee the deputy pro vice-chancellor stepped

the deputy pro vice-chancellor stepped

the deputy pro vice-chancellor stepped in and vetoed it she said we’re not

in and vetoed it she said we’re not

in and vetoed it she said we’re not conducting this sort of research at our

conducting this sort of research at our

conducting this sort of research at our University and we believe this is the

University and we believe this is the

University and we believe this is the result of academic conservativism so

result of academic conservativism so

result of academic conservativism so what do I mean by that well when you

what do I mean by that well when you

what do I mean by that well when you think of people who use illicit drugs

think of people who use illicit drugs

think of people who use illicit drugs most people don’t experience harm yet

most people don’t experience harm yet

most people don’t experience harm yet the research we conduct is focused on

the research we conduct is focused on

the research we conduct is focused on this small group who do experience harm

this small group who do experience harm

this small group who do experience harm it’s been described by Mugford as the

it’s been described by Mugford as the

it’s been described by Mugford as the pathological paradigm of drug use drugs

pathological paradigm of drug use drugs

pathological paradigm of drug use drugs are not illegal because they’re harmful

are not illegal because they’re harmful

are not illegal because they’re harmful they’re perceived as harmful because

they’re perceived as harmful because

they’re perceived as harmful because they’re illegal and only only research

they’re illegal and only only research

they’re illegal and only only research that perpetuates that perception is

that perpetuates that perception is

that perpetuates that perception is funded by the government and this is a

funded by the government and this is a

funded by the government and this is a major barrier to conducting psychedelic

major barrier to conducting psychedelic

major barrier to conducting psychedelic science in Australia because we want to

science in Australia because we want to

science in Australia because we want to demonstrate the therapeutic benefit of

demonstrate the therapeutic benefit of

demonstrate the therapeutic benefit of these potential of these illicit

these potential of these illicit

these potential of these illicit substances further there’s vested

substances further there’s vested

substances further there’s vested interests in people who are delivering

interests in people who are delivering

interests in people who are delivering and investigating the conventional

and investigating the conventional

and investigating the conventional treatments they say they work meanwhile

treatments they say they work meanwhile

treatments they say they work meanwhile institutions are getting significant

institutions are getting significant

institutions are getting significant government funding to perpetuate the

government funding to perpetuate the

government funding to perpetuate the idea that illicit drugs including

idea that illicit drugs including

idea that illicit drugs including psychedelics are harmful this has not

psychedelics are harmful this has not

psychedelics are harmful this has not led us to give up in the past six months

led us to give up in the past six months

led us to give up in the past six months we’ve published the first two papers on

we’ve published the first two papers on

we’ve published the first two papers on psychedelic science in the Australian

psychedelic science in the Australian

psychedelic science in the Australian scientific literature we hope that this

scientific literature we hope that this

scientific literature we hope that this will increase the awareness of academics

will increase the awareness of academics

will increase the awareness of academics increase the awareness of healthcare

increase the awareness of healthcare

increase the awareness of healthcare providers so that we can have another go

providers so that we can have another go

providers so that we can have another go and get mdma-assisted psychotherapy and

and get mdma-assisted psychotherapy and

and get mdma-assisted psychotherapy and other psychedelic research underway in

other psychedelic research underway in

other psychedelic research underway in Australia because if we don’t act now

Australia because if we don’t act now

Australia because if we don’t act now and if we don’t start a psychedelic

and if we don’t start a psychedelic

and if we don’t start a psychedelic science program in Australia hundreds of

science program in Australia hundreds of

science program in Australia hundreds of thousands of Australians will continue

thousands of Australians will continue

thousands of Australians will continue to

to

to Safa war veterans continue to commit

Safa war veterans continue to commit

Safa war veterans continue to commit suicide or MDMA becomes a medicine in

suicide or MDMA becomes a medicine in

suicide or MDMA becomes a medicine in the US so they fly to the u.s. to get

the US so they fly to the u.s. to get

the US so they fly to the u.s. to get treatment how long will it take before

treatment how long will it take before

treatment how long will it take before Australia joins the International

Australia joins the International

Australia joins the International psychedelic Renaissance thank you

psychedelic Renaissance thank you

psychedelic Renaissance thank you [Applause]

”

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *